IRIS

Santopolo, S., Rossi, A., Santoro, M.g. (2017). The proteasome inhibitor bortezomib triggers HSF2 mRNA transcription in cancer cells: role of HSF1. ??????? it.cilea.surplus.oa.citation.tipologie.CitationProceedings.prensentedAt ??????? The 8th International Congress on Stress Proteins in Biology and Medicine: Stress Management Mechanisms and Pathways, Turku, FInland.

The proteasome inhibitor bortezomib triggers HSF2 mRNA transcription in cancer cells: role of HSF1

Santopolo Silvia;Santoro Maria Gabriella
2017-08-14
The 8th International Congress on Stress Proteins in Biology and Medicine: Stress Management Mechanisms and Pathways
Turku, FInland
2017
8th
Lea Sistonen and Larry Hightower
Rilevanza internazionale
contributo
14-ago-2017
14-ago-2017
Settore MED/07 - MICROBIOLOGIA E MICROBIOLOGIA CLINICA
English
Intervento a convegno
Santopolo, S., Rossi, A., Santoro, M.g. (2017). The proteasome inhibitor bortezomib triggers HSF2 mRNA transcription in cancer cells: role of HSF1. ??????? it.cilea.surplus.oa.citation.tipologie.CitationProceedings.prensentedAt ??????? The 8th International Congress on Stress Proteins in Biology and Medicine: Stress Management Mechanisms and Pathways, Turku, FInland.
Santopolo, S; Rossi, A; Santoro, Mg
02 - Intervento a convegno
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/250053
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact